These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15704064)

  • 41. Relationship of plasma brain-type natriuretic peptide levels to left ventricular longitudinal function in patients with congestive heart failure assessed by strain Doppler imaging.
    Yoneyama A; Koyama J; Tomita T; Kumazaki S; Tsutsui H; Watanabe N; Kinoshita O; Ikeda U
    Int J Cardiol; 2008 Oct; 130(1):56-63. PubMed ID: 18068244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy.
    Minami Y; Haruki S; Kanbayashi K; Maeda R; Itani R; Hagiwara N
    Heart Rhythm; 2018 Oct; 15(10):1484-1490. PubMed ID: 29709578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visit-to-Visit B-Type Natriuretic Peptide Variability during the Previous Year Has Independent Prognostic Value in Patients with Stable Chronic Heart Failure.
    Kagiyama N; Yuri T; Hayashida A; Hirohata A; Yamamoto K; Yoshida K
    Cardiology; 2019; 143(3-4):92-99. PubMed ID: 31330506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Predictive value for long term cardiac events by admission B-type natriuretic peptide and pulmonary capillary wedge pressure in patients with chronic heart failure].
    Hu YM; Wang M; Zhao SQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):786-9. PubMed ID: 19102857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction　- Relevance to Age-Related Left Ventricular Modeling in Japanese.
    Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Kuwahara K; Yasue H
    Circ J; 2017 Jun; 81(7):1006-1013. PubMed ID: 28381705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.
    Cabassi A; de Champlain J; Maggiore U; Parenti E; Coghi P; Vicini V; Tedeschi S; Cremaschi E; Binno S; Rocco R; Bonali S; Bianconcini M; Guerra C; Folesani G; Montanari A; Regolisti G; Fiaccadori E
    Int J Cardiol; 2013 Oct; 168(4):3334-9. PubMed ID: 23623341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide.
    Popescu BA; Popescu AC; Antonini-Canterin F; Rubin D; Cappelletti P; Piazza R; Ginghina C; Dimulescu D; Beladan CC; Nicolosi GL
    Echocardiography; 2007 Nov; 24(10):1035-43. PubMed ID: 18001356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
    Vrtovec B; Knezevic I; Poglajen G; Sebestjen M; Okrajsek R; Haddad F
    Am J Cardiol; 2013 Mar; 111(6):886-90. PubMed ID: 23273526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure.
    Nishiyama K; Tsutamoto T; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Circ J; 2011; 75(2):341-7. PubMed ID: 21178290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
    Richards AM; Doughty R; Nicholls MG; MacMahon S; Sharpe N; Murphy J; Espiner EA; Frampton C; Yandle TG;
    J Am Coll Cardiol; 2001 Jun; 37(7):1781-7. PubMed ID: 11401111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.
    Susa T; Kobayashi S; Tanaka T; Murakami W; Akashi S; Kunitsugu I; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Ueyama T; Okamura T; Yano M; Matsuzaki M
    Circ J; 2012; 76(1):117-26. PubMed ID: 22008315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
    Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
    Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure.
    Parissis JT; Nikolaou M; Farmakis D; Bistola V; Paraskevaidis IA; Adamopoulos S; Filippatos G; Kremastinos DT
    Heart; 2008 May; 94(5):585-9. PubMed ID: 17761502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.